190 related articles for article (PubMed ID: 15987601)
21. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
Secchiero P; Milani D; Gonelli A; Melloni E; Campioni D; Gibellini D; Capitani S; Zauli G
J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
[TBL] [Abstract][Full Text] [Related]
22. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.
Emery JG; McDonnell P; Burke MB; Deen KC; Lyn S; Silverman C; Dul E; Appelbaum ER; Eichman C; DiPrinzio R; Dodds RA; James IE; Rosenberg M; Lee JC; Young PR
J Biol Chem; 1998 Jun; 273(23):14363-7. PubMed ID: 9603945
[TBL] [Abstract][Full Text] [Related]
23. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
Mirandola P; Ponti C; Gobbi G; Sponzilli I; Vaccarezza M; Cocco L; Zauli G; Secchiero P; Manzoli FA; Vitale M
Blood; 2004 Oct; 104(8):2418-24. PubMed ID: 15205263
[TBL] [Abstract][Full Text] [Related]
24. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072
[TBL] [Abstract][Full Text] [Related]
25. Functional analysis of TRAIL receptors using monoclonal antibodies.
Griffith TS; Rauch CT; Smolak PJ; Waugh JY; Boiani N; Lynch DH; Smith CA; Goodwin RG; Kubin MZ
J Immunol; 1999 Mar; 162(5):2597-605. PubMed ID: 10072501
[TBL] [Abstract][Full Text] [Related]
26. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.
Mérino D; Lalaoui N; Morizot A; Schneider P; Solary E; Micheau O
Mol Cell Biol; 2006 Oct; 26(19):7046-55. PubMed ID: 16980609
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.
Jaganathan J; Petit JH; Lazio BE; Singh SK; Chin LS
Neurosurg Focus; 2002 Sep; 13(3):ecp1. PubMed ID: 15844877
[TBL] [Abstract][Full Text] [Related]
28. Characterization of tumour necrosis factor-alpha-related apoptosis-inducing ligand and its receptors in the adult human testis.
Grataroli R; Vindrieux D; Selva J; Felsenheld C; Ruffion A; Decaussin M; Benahmed M
Mol Hum Reprod; 2004 Feb; 10(2):123-8. PubMed ID: 14742697
[TBL] [Abstract][Full Text] [Related]
29. Increased sensitivity to TRAIL-induced apoptosis occurs during the adenoma to carcinoma transition of colorectal carcinogenesis.
Hague A; Hicks DJ; Hasan F; Smartt H; Cohen GM; Paraskeva C; MacFarlane M
Br J Cancer; 2005 Feb; 92(4):736-42. PubMed ID: 15685228
[TBL] [Abstract][Full Text] [Related]
30. Tissue distribution of the death ligand TRAIL and its receptors.
Spierings DC; de Vries EG; Vellenga E; van den Heuvel FA; Koornstra JJ; Wesseling J; Hollema H; de Jong S
J Histochem Cytochem; 2004 Jun; 52(6):821-31. PubMed ID: 15150291
[TBL] [Abstract][Full Text] [Related]
31. Uveal melanoma expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors and susceptibility to TRAIL-induced apoptosis.
Ren DH; Mayhew E; Hay C; Li H; Alizadeh H; Niederkorn JY
Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1162-8. PubMed ID: 15037583
[TBL] [Abstract][Full Text] [Related]
32. TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus.
Washburn B; Weigand MA; Grosse-Wilde A; Janke M; Stahl H; Rieser E; Sprick MR; Schirrmacher V; Walczak H
J Immunol; 2003 Feb; 170(4):1814-21. PubMed ID: 12574346
[TBL] [Abstract][Full Text] [Related]
33. How TRAIL kills cancer cells, but not normal cells.
Gura T
Science; 1997 Aug; 277(5327):768. PubMed ID: 9273698
[No Abstract] [Full Text] [Related]
34. TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus.
Matsuyama W; Yamamoto M; Higashimoto I; Oonakahara K; Watanabe M; Machida K; Yoshimura T; Eiraku N; Kawabata M; Osame M; Arimura K
Blood; 2004 Jul; 104(1):184-91. PubMed ID: 15001474
[TBL] [Abstract][Full Text] [Related]
35. TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy.
Lincz LF; Yeh TX; Spencer A
Leukemia; 2001 Oct; 15(10):1650-7. PubMed ID: 11587225
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of TRAIL and TRAIL receptors in allergic asthmatics following segmental antigen challenge: evidence for a role of TRAIL in eosinophil survival.
Robertson NM; Zangrilli JG; Steplewski A; Hastie A; Lindemeyer RG; Planeta MA; Smith MK; Innocent N; Musani A; Pascual R; Peters S; Litwack G
J Immunol; 2002 Nov; 169(10):5986-96. PubMed ID: 12421985
[TBL] [Abstract][Full Text] [Related]
37. Rel/NF-kappaB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1.
Bernard D; Quatannens B; Vandenbunder B; Abbadie C
J Biol Chem; 2001 Jul; 276(29):27322-8. PubMed ID: 11350953
[TBL] [Abstract][Full Text] [Related]
38. Molecular determinants of response to TRAIL in killing of normal and cancer cells.
Kim K; Fisher MJ; Xu SQ; el-Deiry WS
Clin Cancer Res; 2000 Feb; 6(2):335-46. PubMed ID: 10690508
[TBL] [Abstract][Full Text] [Related]
39. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D.
Olsson A; Diaz T; Aguilar-Santelises M; Osterborg A; Celsing F; Jondal M; Osorio LM
Leukemia; 2001 Dec; 15(12):1868-77. PubMed ID: 11753607
[TBL] [Abstract][Full Text] [Related]
40. Expression of TRAIL and its receptors in human brain tumors.
Frank S; Köhler U; Schackert G; Schackert HK
Biochem Biophys Res Commun; 1999 Apr; 257(2):454-9. PubMed ID: 10198234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
